Oncology
Tiffany Traina, MD
Vice Chair, Department of Medicine; Section Head, Triple Negative Breast Cancer Clinical Research Program
Dr. Tiffany A. Traina is a board-certified medical oncologist whose clinical practice is dedicated exclusively to patients with all stages of breast cancer. She specializes in triple-negative breast cancer (TNBC), a particularly aggressive subtype that lacks estrogen receptor, progesterone receptor, and HER2 protein expression. Her research focuses on developing novel targeted therapies for TNBC, including investigation of androgen receptor inhibition, PARP inhibitors, and src inhibitors. Dr. Tr
25+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (ABIM)
- Internal Medicine
Education & Training
- Weill Medical College of Cornell University — M.D., 1999
- NewYork-Presbyterian Hospital/Weill Cornell Medical Center — Residency, Internal Medicine, 1999-2002
- Memorial Sloan Kettering Cancer Center — Fellowship, Hematology & Oncology, 2003-2006
Peer Recognition
- Castle Connolly — Top Doctor
2024-2026 (3 years)
2025
Recognition & Leadership
Awards & Honors
- Fellow, American Society of Clinical Oncology (2023)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Memorial Sloan Kettering Cancer Center
- Lancaster General Hospital
- Staten Island University Hospital
Languages
English
Experience
25+ years in practice